{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:09:06Z","timestamp":1793862546566,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"DOI":"10.1186\/s40794-025-00246-3","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:02:43Z","timestamp":1747245763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The role of mRNA vaccines in infectious diseases: a new era of immunization"],"prefix":"10.1186","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-2946-2668","authenticated-orcid":false,"given":"Kesaobaka","family":"Batisani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"246_CR1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268819001298","author":"E Colzani","year":"2019","unstructured":"Colzani E. Beyond morbidity and mortality: the burden of infectious diseases on healthcare services. Epidemiol Infect. 2019. https:\/\/doi.org\/10.1017\/S0950268819001298. 147.","journal-title":"Epidemiol Infect"},{"issue":"1","key":"246_CR2","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3390\/microorganisms12010146","volume":"12","author":"A Bennasar-Figueras","year":"2024","unstructured":"Bennasar-Figueras A. The natural and clinical history of Plague: from the ancient pandemics to modern insights. Microorganisms. 2024;12(1):146. https:\/\/doi.org\/10.3390\/microorganisms12010146.","journal-title":"Microorganisms"},{"key":"246_CR3","doi-asserted-by":"publisher","unstructured":"Baafi J, Io D, Fw A. Vaccination as a control of Infectious diseases. J Appl Comput Math. 2017;2017. https:\/\/doi.org\/10.4172\/21689679.1000357.","DOI":"10.4172\/21689679.1000357"},{"key":"246_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1080\/17513758.2014.986545","volume":"9","author":"S Rahman","year":"2015","unstructured":"Rahman S, Zou X. Modeling the impact of vaccination on infectious diseases dynamics. J Biol Dyn. 2015;9:307\u201320. https:\/\/doi.org\/10.1080\/17513758.2014.986545.","journal-title":"J Biol Dyn"},{"key":"246_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/d41573-020-00073-5","volume":"19","author":"T Le","year":"2020","unstructured":"Le T, Andreadakis Z, Kumar A, Rom\u00e1n R, Tollefsen S, Saville M, Mayhew S. The COVID-19 vaccine development landscape. Nat Rev Drug Discovery. 2020;19:305\u20136. https:\/\/doi.org\/10.1038\/d41573-020-00073-5.","journal-title":"Nat Rev Drug Discovery"},{"key":"246_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","volume":"333","author":"R Verbeke","year":"2021","unstructured":"Verbeke R, Lentacker I, Smedt S, Dewitte H. The dawn of mRNA vaccines: the COVID-19 case. J Controlled Release. 2021;333:511\u201320. https:\/\/doi.org\/10.1016\/j.jconrel.2021.03.043.","journal-title":"J Controlled Release"},{"key":"246_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2019.10.002","author":"S Linares-Fern\u00e1ndez","year":"2019","unstructured":"Linares-Fern\u00e1ndez S, Lacroix C, Exposito J, Verrier B. Tailoring mRNA vaccine to Balance Innate\/Adaptive Immune Response. Trends Mol Med. 2019. https:\/\/doi.org\/10.1016\/j.molmed.2019.10.002.","journal-title":"Trends Mol Med"},{"issue":"33","key":"246_CR8","doi-asserted-by":"publisher","first-page":"3882","DOI":"10.1016\/j.vaccine.2016.05.046","volume":"34","author":"A Kowalczyk","year":"2016","unstructured":"Kowalczyk A, Doener F, Zanzinger K, Noth J, Baumhof P, Fotin-Mleczek M, Heidenreich R. Self-adjuvanted mRNA vaccines induce local innate immune responses that lead to a potent and boostable adaptive immunity. Vaccine. 2016;34(33):3882\u201393. https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.046.","journal-title":"Vaccine"},{"key":"246_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.addr.2014.10.002","volume":"93","author":"J Tlaxca","year":"2015","unstructured":"Tlaxca J, Ellis S, Remmele R. Live attenuated and inactivated viral vaccine formulation and nasal delivery: potential and challenges. Adv Drug Deliv Rev. 2015;93:56\u201378. https:\/\/doi.org\/10.1016\/j.addr.2014.10.002.","journal-title":"Adv Drug Deliv Rev"},{"key":"246_CR10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1080\/14760584.2017.1355245","volume":"16","author":"C Iavarone","year":"2017","unstructured":"Iavarone C, O\u2019hagan D, Yu D, Delahaye N, Ulmer J. Mechanism of action of mRNA-based vaccines. Expert Rev Vaccines. 2017;16:871\u201381. https:\/\/doi.org\/10.1080\/14760584.2017.1355245.","journal-title":"Expert Rev Vaccines"},{"key":"246_CR11","unstructured":"Thapa BB. (2024). non-replicating mRNA vaccine for the COVID-19 spike protein. [online] BIORENDER. Available at: https:\/\/app.biorender.com\/illustrations\/674efbf13d89227378c399ec"},{"key":"246_CR12","doi-asserted-by":"publisher","unstructured":"Buschmann M, Carrasco M, Alishetty S, Paige M, Alameh M, Weissman D. Nanomaterial Delivery systems for mRNA vaccines. Vaccines. 2021;9. https:\/\/doi.org\/10.3390\/vaccines9010065.","DOI":"10.3390\/vaccines9010065"},{"key":"246_CR13","doi-asserted-by":"publisher","unstructured":"Yasar H, Biehl A, De Rossi C, Koch M, Murgia X, Loretz B, Lehr C. Kinetics of mRNA delivery and protein translation in dendritic cells using lipid-coated PLGA nanoparticles. J Nanobiotechnol. 2018;16. https:\/\/doi.org\/10.1186\/s12951-018-0401-y.","DOI":"10.1186\/s12951-018-0401-y"},{"key":"246_CR14","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c04996","author":"R Tenchov","year":"2021","unstructured":"Tenchov R, Bird R, Curtze A, Zhou Q. Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a Landscape of Research Diversity and Advancement. ACS Nano. 2021. https:\/\/doi.org\/10.1021\/acsnano.1c04996.","journal-title":"ACS Nano"},{"key":"246_CR15","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.4049\/jimmunol.2100637","volume":"207","author":"S Bansal","year":"2021","unstructured":"Bansal S, Perincheri S, Fleming T, Poulson C, Tiffany B, Bremner R, Mohanakumar T. Cutting Edge: circulating exosomes with COVID spike protein are Induced by BNT162b2 (Pfizer\u2013BioNTech) Vaccination prior to development of antibodies: a novel mechanism for Immune activation by mRNA vaccines. J Immunol. 2021;207:2405\u201310. https:\/\/doi.org\/10.4049\/jimmunol.2100637.","journal-title":"J Immunol"},{"key":"246_CR16","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1084\/jem.20171450","volume":"215","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan M, Naradikian M, Parkhouse K, Cain D, Jones L, Moody M, Verkerke H, Myles A, Willis E, Labranche C, Montefiori D, Lobby J, Saunders K, Liao H, Korber B, Sutherland L, Scearce R, Hraber P, Tomb\u00e1cz I, Muramatsu H, Ni H, Balikov D, Li C, Mui B, Tam Y, Krammer F, Karik\u00f3 K, Polacino P, Eisenlohr L, Madden T, Hope M, Lewis M, Lee K, Hu S, Hensley S, Cancro M, Haynes B, Weissman D. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses. J Exp Med. 2018;215:1571\u201388. https:\/\/doi.org\/10.1084\/jem.20171450.","journal-title":"J Exp Med"},{"issue":"7876","key":"246_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/d41586-021-02483-w","volume":"597","author":"E Dolgin","year":"2021","unstructured":"Dolgin E. The tangled history of mRNA vaccines. Nature. 2021;597(7876):318\u201324. https:\/\/doi.org\/10.1038\/d41586-021-02483-w.","journal-title":"Nature"},{"key":"246_CR18","doi-asserted-by":"publisher","unstructured":"Yang L, Gong L, Wang P, Zhao X, Zhao F, Zhang Z, Li Y, Huang W. Recent advances in lipid nanoparticles for delivery of mRNA. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14122682.","DOI":"10.3390\/pharmaceutics14122682"},{"key":"246_CR19","doi-asserted-by":"publisher","unstructured":"Baptista B, Carapito R, Laroui N, Pichon C, Sousa F. mRNA, a Revolution in Biomedicine. Pharmaceutics, 2021;13(12):2090. https:\/\/doi.org\/10.3390\/pharmaceutics13122090","DOI":"10.3390\/pharmaceutics13122090"},{"key":"246_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.smim.2017.08.015","volume":"34","author":"Y Granot","year":"2017","unstructured":"Granot Y, Peer D. Delivering the right message: challenges and opportunities in lipid nanoparticles-mediated modified mRNA therapeutics-An innate immune system standpoint. Semin Immunol. 2017;34:68\u201377. https:\/\/doi.org\/10.1016\/j.smim.2017.08.015.","journal-title":"Semin Immunol"},{"issue":"1","key":"246_CR21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41392-024-02002-z","volume":"9","author":"Y Shi","year":"2024","unstructured":"Shi Y, Shi M, Wang Y, You J. Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications. Signal Transduct Target Therapy. 2024;9(1):322. https:\/\/doi.org\/10.1038\/s41392-024-02002-z.","journal-title":"Signal Transduct Target Therapy"},{"key":"246_CR22","doi-asserted-by":"publisher","unstructured":"Bajema K, Dahl R, Evener S, Prill M, Rodriguez-Barradas M, Marconi V, Beenhouwer D, Holodniy M, Lucero-Obusan C, Brown S, Tremarelli M, Epperson M, Mills L, Park S, Rivera-Dominguez G, Morones R, Ahmadi-Izadi G, Deovi\u0107 R, Mendoza C, Jeong C, Schrag S, Meites E, Hall A, Kobayashi M, McMorrow M, Verani J, Thornburg N, Surie D, Burnette J, Capo G, Epstein L, Gallini J, Harrison T, Hartley A, Hernandez L, Morales E, Patel N, Rooney K, Tanner T, Tate E, Tunson A, Whitmire A, Winston J, Elliot K, Graham I, Lama D, Pena I, Perea A, Perez G, Simelane J, Smith S, Tallin G, Tisi A, Lopez A, Gonzalez M, Lengi B, Tamez M, Aryanfar B, Lee-Chang I, Matolek A, Poteshkina A, Naeem S, Goldin E, Agrawal M, L\u00f3pez J, Peters T, Kudryavtseva G, Cates J, Kambhampati A. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans \u2014 Five Veterans Affairs Medical Centers, United States, February 1\u2013September 30, 2021. Morbidity and Mortality Weekly Report, 2021;70:1700\u20131705. https:\/\/doi.org\/10.15585\/mmwr.mm7049a2","DOI":"10.15585\/mmwr.mm7049a2"},{"key":"246_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2021.12.033","volume":"185","author":"W Garc\u00eda-Beltr\u00e1n","year":"2021","unstructured":"Garc\u00eda-Beltr\u00e1n W, Denis K, Hoelzemer A, Lam E, Nitido A, Sheehan M, Berr\u00edos C, Ofoman O, Chang C, Hauser B, Feldman J, Roederer A, Gregory D, Poznansky M, Schmidt A, Iafrate A, Naranbhai V, Balazs A. mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. 2021;185:457\u2013e4664. https:\/\/doi.org\/10.1016\/j.cell.2021.12.033.","journal-title":"Cell"},{"key":"246_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0159-8","author":"N Jackson","year":"2020","unstructured":"Jackson N, Kester K, Casimiro D, Gurunathan S, Derosa F. The promise of mRNA vaccines: a biotech and industrial perspective. NPJ Vaccines. 2020. https:\/\/doi.org\/10.1038\/s41541-020-0159-8. 5.","journal-title":"NPJ Vaccines"},{"key":"246_CR25","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","volume":"39","author":"S Rosa","year":"2021","unstructured":"Rosa S, Prazeres D, Azevedo A, Marques M. mRNA vaccines manufacturing: challenges and bottlenecks. Vaccine. 2021;39:2190\u2013200. https:\/\/doi.org\/10.1016\/j.vaccine.2021.03.038.","journal-title":"Vaccine"},{"key":"246_CR26","doi-asserted-by":"publisher","unstructured":"Knezevic I, Liu M, Peden K, Zhou T, Kang H. Development of mRNA vaccines: Scientific and Regulatory issues. Vaccines. 2021;9. https:\/\/doi.org\/10.3390\/vaccines9020081.","DOI":"10.3390\/vaccines9020081"},{"issue":"3","key":"246_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.46683\/jmvi.2020.17","volume":"1","author":"Tano\u011fluE G\u00fczel","year":"2020","unstructured":"G\u00fczel Tano\u011fluE. Production and distribution of mRNA vaccines: SARS-CoV-2 experience. J Mol Virol Immunol. 2020;1(3):27\u201334.","journal-title":"J Mol Virol Immunol"},{"key":"246_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.608460","author":"J Sandbrink","year":"2020","unstructured":"Sandbrink J, Shattock R. RNA vaccines: a suitable platform for tackling emerging pandemics? Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.608460. 11.","journal-title":"Front Immunol"},{"key":"246_CR29","unstructured":"CDC (2024). Coronavirus Disease 2019 (COVID-19) Vaccine Safety. [online] Vaccine Safety. Available at: https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/covid-19.html"},{"issue":"12","key":"246_CR30","doi-asserted-by":"publisher","first-page":"e2140364","DOI":"10.1001\/jamanetworkopen.2021.40364","volume":"4","author":"AL Beatty","year":"2021","unstructured":"Beatty AL, Peyser ND, Butcher XE, Cocohoba JM, Lin F, Olgin JE, Pletcher MJ, Marcus GM. Analysis of COVID-19 vaccine type and adverse effects following vaccination. JAMA Netw open. 2021;4(12):e2140364. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.40364.","journal-title":"JAMA Netw open"},{"issue":"6","key":"246_CR31","doi-asserted-by":"publisher","first-page":"e1004245","DOI":"10.1371\/journal.pmed.1004245","volume":"20","author":"J Stowe","year":"2023","unstructured":"Stowe J, Miller E, Andrews N, Whitaker HJ. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: a self-controlled case series analysis in England. PLoS Med. 2023;20(6):e1004245. https:\/\/doi.org\/10.1371\/journal.pmed.1004245.","journal-title":"PLoS Med"},{"key":"246_CR32","doi-asserted-by":"publisher","first-page":"971","DOI":"10.15585\/mmwr.mm7130a4","volume":"71","author":"A Hause","year":"2022","unstructured":"Hause A, Baggs J, Marquez P, Abara W, Baumblatt J, Blanc P, Su J, Hugueley B, Parker C, Myers T, Gee J, Shimabukuro T, Shay D. Safety Monitoring of COVID-19 mRNA vaccine second booster doses among adults aged\u2009\u2265\u200950 years \u2014 United States, March 29, 2022\u2013July 10, 2022. Morb Mortal Wkly Rep. 2022;71:971\u20136. https:\/\/doi.org\/10.15585\/mmwr.mm7130a4.","journal-title":"Morb Mortal Wkly Rep"},{"key":"246_CR33","unstructured":"CDC. (2024). Coronavirus Disease 2019 (COVID-19) Vaccine Safety. Vaccine Safety. https:\/\/www.cdc.gov\/vaccine-safety\/vaccines\/covid-19.html"},{"key":"246_CR34","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/j.vaccine.2021.02.007","volume":"39","author":"L Chu","year":"2021","unstructured":"Chu L, McPhee R, Huang W, Bennett H, Pajon R, Nestorova B, Leav B. A preliminary report of a randomized controlled phase 2 trial of the safety and immunogenicity of mRNA-1273 SARS-CoV-2 vaccine. Vaccine. 2021;39:2791\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2021.02.007.","journal-title":"Vaccine"},{"key":"246_CR35","doi-asserted-by":"publisher","unstructured":"Xu S, Yang K, Li R, Zhang L. mRNA vaccine Era\u2014Mechanisms, drug platform and clinical prospection. Int J Mol Sci. 2020;21. https:\/\/doi.org\/10.3390\/ijms21186582.","DOI":"10.3390\/ijms21186582"},{"key":"246_CR36","doi-asserted-by":"publisher","unstructured":"Uddin M, Roni M. Challenges of Storage and Stability of mRNA-Based COVID-19 vaccines. Vaccines. 2021;9. https:\/\/doi.org\/10.3390\/vaccines9091033.","DOI":"10.3390\/vaccines9091033"},{"issue":"3","key":"246_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.18683\/germs.2021.1280","volume":"11","author":"IO Ayenigbara","year":"2021","unstructured":"Ayenigbara IO, Adegboro JS, Ayenigbara GO, Adeleke OR, Olofintuyi OO. The challenges to a successful COVID-19 vaccination programme in Africa. Germs. 2021;11(3):427\u201340. https:\/\/doi.org\/10.18683\/germs.2021.1280.","journal-title":"Germs"},{"key":"246_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/ckaa166.975","author":"M Siddique","year":"2020","unstructured":"Siddique M, Abdullah S, Siddiqi D, Mirza A, Dharma V, Shah M, Akhter M, Khan A, Chandir S. Using mobile immunization vans to cover under-served populations in hard-to-reach areas. Eur J Pub Health. 2020. https:\/\/doi.org\/10.1093\/eurpub\/ckaa166.975.","journal-title":"Eur J Pub Health"},{"key":"246_CR39","doi-asserted-by":"publisher","unstructured":"Duan Y, Shi J, Wang Z, Zhou S, Jin Y, Zheng Z. Disparities in COVID-19 vaccination among Low-, Middle-, and high-income countries: the mediating role of Vaccination Policy. Vaccines. 2021;9. https:\/\/doi.org\/10.3390\/vaccines9080905.","DOI":"10.3390\/vaccines9080905"},{"key":"246_CR40","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1126\/science.abc5312","volume":"368","author":"L Corey","year":"2020","unstructured":"Corey L, Mascola J, Fauci A, Collins F. A strategic approach to COVID-19 vaccine R&D. Science. 2020;368:948\u201350. https:\/\/doi.org\/10.1126\/science.abc5312.","journal-title":"Science"},{"key":"246_CR41","unstructured":"Ritchie EMH, Rod\u00e9s-Guirao L, Appel C, Gavrilov D, Giattino C, Hasell J, Macdonald B, Dattani S, Beltekian D, Esteban Ortiz-Ospina and Max Roser. (2020) - Coronavirus (COVID-19) Vaccinations Published online at OurWorldinData.org. Retrieved from: \u2018https:\/\/ourworldindata.org\/covid-vaccinations\u2019 [Online Resource]."},{"key":"246_CR42","doi-asserted-by":"publisher","unstructured":"Kowalzik F, Schreiner D, Jensen C, Teschner D, Gehring S, Zepp F. mRNA-Based Vaccines. Vaccines, 9, 2021. https:\/\/doi.org\/10.3390\/vaccines9040390","DOI":"10.3390\/vaccines9040390"},{"key":"246_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-024-02121-1","author":"F Freier","year":"2024","unstructured":"Freier F. Combined COVID-flu vaccines are coming: Moderna jab clears major test. Nature. 2024. https:\/\/doi.org\/10.1038\/d41586-024-02121-1.","journal-title":"Nature"},{"key":"246_CR44","unstructured":"Pfizer. and BioNTech Provide Update on mRNA-based Combination Vaccine Program Against Influenza and COVID-19 in Individuals 18\u201364 Years of Age| Pfizer. (2024). Pfizer.com. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-provide-update-mrna-based-combination"},{"key":"246_CR45","doi-asserted-by":"publisher","unstructured":"Matarazzo L, Bettencourt P. mRNA vaccines: a new opportunity for malaria, Tuberculosis and HIV. Front Immunol. 2023;14. https:\/\/doi.org\/10.3389\/fimmu.2023.1172691.","DOI":"10.3389\/fimmu.2023.1172691"},{"key":"246_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/COH.0000000000000815","volume":"18","author":"K Chinyenze","year":"2023","unstructured":"Chinyenze K, Nduati E, Muturi-Kioi V. Accelerating HIV vaccine development through meaningful engagement of local scientists and communities. Curr Opin HIV AIDS. 2023;18:284\u20139. https:\/\/doi.org\/10.1097\/COH.0000000000000815.","journal-title":"Curr Opin HIV AIDS"},{"key":"246_CR47","doi-asserted-by":"publisher","unstructured":"Parums D. Editorial: mRNA vaccines and immunotherapy in Oncology: a new era for Personalized Medicine. Med Sci Monitor: Int Med J Experimental Clin Res. 2021;27. https:\/\/doi.org\/10.12659\/MSM.933088. e933088-1 - e933088-2.","DOI":"10.12659\/MSM.933088"},{"key":"246_CR48","doi-asserted-by":"publisher","unstructured":"Sahin, U., Derhovanessian, E., Miller, M., Kloke, B. P., Simon, P., L\u00f6wer, M., Bukur,V., Tadmor, A. D., Luxemburger, U., Schr\u00f6rs, B., Omokoko, T., Vormehr, M., Albrecht,C., Paruzynski, A., Kuhn, A. N., Buck, J., Heesch, S., Schreeb, K. H., M\u00fcller, F.,Ortseifer, I.,\u2026 T\u00fcreci, \u00d6. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature, 2017;547(7662):222\u2013226. https:\/\/doi.org\/10.1038\/nature23003.","DOI":"10.1038\/nature23003"},{"key":"246_CR49","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature23003","volume":"547","author":"U \u015eahin","year":"2017","unstructured":"\u015eahin U, Derhovanessian E, Miller M, Kloke B, Simon P, L\u00f6wer M, Bukur V, Tadmor A, Luxemburger U, Schr\u00f6rs B, Omokoko T, Vormehr M, Albrecht C, Paruzynski A, Kuhn A, Buck J, Heesch S, Schreeb K, Mueller F, Ortseifer I, Vogler I, Godehardt E, Attig S, Rae R, Breitkreuz A, Tolliver C, Suchan M, Martic G, Hohberger A, Sorn P, Diekmann J, Ciesla J, Waksmann O, Br\u00fcck A, Witt M, Zillgen M, Rothermel A, Kasemann B, Langer D, Bolte S, Diken M, Kreiter S, Nemecek R, Gebhardt C, Grabbe S, H\u00f6ller C, Utikal J, Huber C, Loquai C, T\u00fcreci \u00d6. Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer. Nature. 2017;547:222\u20136. https:\/\/doi.org\/10.1038\/nature23003.","journal-title":"Nature"},{"key":"246_CR50","doi-asserted-by":"publisher","unstructured":"Owolabi P, Adam Y, Adebiyi E. Personalizing medicine in Africa: current state, progress and challenges. Front Genet. 2023;14. https:\/\/doi.org\/10.3389\/fgene.2023.1233338.","DOI":"10.3389\/fgene.2023.1233338"},{"key":"246_CR51","doi-asserted-by":"publisher","unstructured":"Kairuz D, Samudh N, Ely A, Arbuthnot P, Bloom K. Advancing mRNA technologies for therapies and vaccines: an African context. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.1018961.","DOI":"10.3389\/fimmu.2022.1018961"}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-025-00246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-025-00246-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-025-00246-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T18:02:46Z","timestamp":1747245766000},"score":1,"resource":{"primary":{"URL":"https:\/\/tdtmvjournal.biomedcentral.com\/articles\/10.1186\/s40794-025-00246-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["246"],"URL":"https:\/\/doi.org\/10.1186\/s40794-025-00246-3","relation":{},"ISSN":["2055-0936"],"issn-type":[{"value":"2055-0936","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"assertion":[{"value":"17 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics declaration not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The lead author Kesaobaka Batisani affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Transparency Statement"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}